Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more
Elekta AB (publ) (EKTAF) - Net Assets
Latest net assets as of October 2025: $890.81 Million USD
Based on the latest financial reports, Elekta AB (publ) (EKTAF) has net assets worth $890.81 Million USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.96 Billion) and total liabilities ($2.07 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $890.81 Million |
| % of Total Assets | 30.08% |
| Annual Growth Rate | 8.78% |
| 5-Year Change | 7.94% |
| 10-Year Change | 37.99% |
| Growth Volatility | 12.2 |
Elekta AB (publ) - Net Assets Trend (2002–2025)
This chart illustrates how Elekta AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Elekta AB (publ) (2002–2025)
The table below shows the annual net assets of Elekta AB (publ) from 2002 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $8.85 Billion | -17.92% |
| 2024-04-30 | $10.78 Billion | +10.76% |
| 2023-04-30 | $9.73 Billion | +9.16% |
| 2022-04-30 | $8.92 Billion | +8.77% |
| 2021-04-30 | $8.20 Billion | +1.04% |
| 2020-04-30 | $8.11 Billion | +4.29% |
| 2019-04-30 | $7.78 Billion | +11.34% |
| 2018-04-30 | $6.99 Billion | +3.14% |
| 2017-04-30 | $6.77 Billion | +5.65% |
| 2016-04-30 | $6.41 Billion | -3.51% |
| 2015-04-30 | $6.64 Billion | +6.20% |
| 2014-04-30 | $6.26 Billion | +12.54% |
| 2013-04-30 | $5.56 Billion | +11.00% |
| 2012-04-30 | $5.01 Billion | +30.68% |
| 2011-04-30 | $3.83 Billion | +18.16% |
| 2010-04-30 | $3.24 Billion | +26.97% |
| 2009-04-30 | $2.56 Billion | +40.93% |
| 2008-04-30 | $1.81 Billion | -3.00% |
| 2007-04-30 | $1.87 Billion | +0.05% |
| 2006-04-30 | $1.87 Billion | +10.27% |
| 2005-04-30 | $1.69 Billion | +19.89% |
| 2004-04-30 | $1.41 Billion | -2.21% |
| 2003-04-30 | $1.45 Billion | +13.07% |
| 2002-04-30 | $1.28 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Elekta AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4482.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $6.64 Billion | 75.49% |
| Common Stock | $192.00 Million | 2.18% |
| Other Components | $1.97 Billion | 22.33% |
| Total Equity | $8.80 Billion | 100.00% |
Elekta AB (publ) Competitors by Market Cap
The table below lists competitors of Elekta AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Koza Altin Islemeleri A S
PINK:KOZAY
|
$1.82 Billion |
|
Schaeffler India Limited
NSE:SCHAEFFLER
|
$1.82 Billion |
|
Exosens
F:H8Y
|
$1.82 Billion |
|
Sumco Corporation
PINK:SUMCF
|
$1.82 Billion |
|
Aerospace CH UAV Co Ltd
SHE:002389
|
$1.81 Billion |
|
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI
|
$1.81 Billion |
|
National Storage REIT
PINK:NTSGF
|
$1.81 Billion |
|
Shanghai V-Test Semiconductor Tech Co. Ltd. A
SHG:688372
|
$1.81 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Elekta AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,775,000,000 to 8,803,000,000, a change of -1,972,000,000 (-18.3%).
- Net income of 237,000,000 contributed positively to equity growth.
- Dividend payments of 917,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 2,460,000,000.
- Other factors increased equity by 1,168,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $237.00 Million | +2.69% |
| Dividends Paid | $917.00 Million | -10.42% |
| Other Comprehensive Income | $-2.46 Billion | -27.95% |
| Other Changes | $1.17 Billion | +13.27% |
| Total Change | $- | -18.30% |
Book Value vs Market Value Analysis
This analysis compares Elekta AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.25x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.75x to 0.25x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-04-30 | $3.25 | $5.69 | x |
| 2003-04-30 | $3.68 | $5.69 | x |
| 2004-04-30 | $3.61 | $5.69 | x |
| 2005-04-30 | $4.50 | $5.69 | x |
| 2006-04-30 | $4.93 | $5.69 | x |
| 2007-04-30 | $4.93 | $5.69 | x |
| 2008-04-30 | $4.85 | $5.69 | x |
| 2009-04-30 | $6.92 | $5.69 | x |
| 2010-04-30 | $8.72 | $5.69 | x |
| 2011-04-30 | $10.14 | $5.69 | x |
| 2012-04-30 | $13.15 | $5.69 | x |
| 2013-04-30 | $14.57 | $5.69 | x |
| 2014-04-30 | $15.60 | $5.69 | x |
| 2015-04-30 | $17.41 | $5.69 | x |
| 2016-04-30 | $16.79 | $5.69 | x |
| 2017-04-30 | $17.77 | $5.69 | x |
| 2018-04-30 | $18.29 | $5.69 | x |
| 2019-04-30 | $20.36 | $5.69 | x |
| 2020-04-30 | $21.23 | $5.69 | x |
| 2021-04-30 | $21.45 | $5.69 | x |
| 2022-04-30 | $23.33 | $5.69 | x |
| 2023-04-30 | $25.44 | $5.69 | x |
| 2024-04-30 | $28.20 | $5.69 | x |
| 2025-04-30 | $23.04 | $5.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Elekta AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.69%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.32%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 3.29x
- Recent ROE (2.69%) is below the historical average (15.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 11.45% | 5.30% | 1.08x | 2.00x | $18.40 Million |
| 2003 | 16.19% | 8.41% | 0.94x | 2.05x | $89.50 Million |
| 2004 | 17.55% | 8.55% | 0.94x | 2.18x | $106.70 Million |
| 2005 | 14.94% | 8.03% | 0.70x | 2.66x | $83.60 Million |
| 2006 | 16.27% | 6.88% | 0.84x | 2.83x | $117.20 Million |
| 2007 | 18.74% | 7.69% | 0.84x | 2.88x | $162.30 Million |
| 2008 | 22.90% | 8.09% | 0.80x | 3.52x | $231.50 Million |
| 2009 | 21.66% | 8.25% | 0.84x | 3.12x | $297.10 Million |
| 2010 | 25.84% | 11.34% | 0.87x | 2.63x | $513.70 Million |
| 2011 | 26.91% | 13.04% | 0.88x | 2.34x | $647.80 Million |
| 2012 | 24.55% | 13.56% | 0.59x | 3.05x | $727.20 Million |
| 2013 | 24.16% | 12.96% | 0.63x | 2.94x | $785.30 Million |
| 2014 | 18.37% | 10.73% | 0.60x | 2.86x | $523.10 Million |
| 2015 | 8.32% | 5.09% | 0.51x | 3.19x | $-111.70 Million |
| 2016 | 2.14% | 1.22% | 0.57x | 3.06x | $-503.20 Million |
| 2017 | 1.85% | 1.17% | 0.51x | 3.11x | $-552.40 Million |
| 2018 | 19.29% | 11.65% | 0.48x | 3.45x | $649.30 Million |
| 2019 | 15.40% | 8.84% | 0.56x | 3.13x | $420.20 Million |
| 2020 | 13.36% | 7.42% | 0.51x | 3.50x | $272.80 Million |
| 2021 | 15.30% | 9.11% | 0.55x | 3.03x | $434.30 Million |
| 2022 | 12.95% | 7.93% | 0.54x | 3.00x | $262.70 Million |
| 2023 | 9.69% | 5.59% | 0.56x | 3.10x | $-29.90 Million |
| 2024 | 12.08% | 7.19% | 0.58x | 2.92x | $224.50 Million |
| 2025 | 2.69% | 1.32% | 0.62x | 3.29x | $-643.30 Million |
Industry Comparison
This section compares Elekta AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Elekta AB (publ) (EKTAF) | $890.81 Million | 11.45% | 2.33x | $1.81 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |